Humana Announces New Agreement With Interwell Health That Expands Comprehensive Care For Members Living With Chronic Kidney Disease
Portfolio Pulse from Happy Mohamed
Humana Inc. (NYSE:HUM) and Interwell Health have announced a new value-based care agreement for Humana Medicare Advantage HMO and PPO members living with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The agreement, which covers 13 states, provides access to Interwell's comprehensive care and specialized resources, including 1,700 network nephrologists, renal care coordinators, and in-home virtual support. The collaboration aims to improve patient health outcomes and quality of life while lowering the total cost of care.
August 23, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Humana's new agreement with Interwell Health could potentially improve patient outcomes and lower costs, which may enhance Humana's reputation and customer satisfaction.
The new agreement provides Humana's members with access to comprehensive care and specialized resources, which could lead to improved patient outcomes. This, in turn, could enhance Humana's reputation and customer satisfaction, potentially leading to increased customer retention and attracting new customers. Therefore, this news could have a positive impact on Humana's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100